Nocturnal electrobioimpedance volumetric assessment (NEVA) is a procedure that can measure penile volume changes together with the number and duration of nocturnal erectile events. This study was conducted to evaluate the different NEVA patterns in diabetic patients with erectile dysfunction (ED), and demonstrate the extent to which tadalafil may affect the characteristics of nocturnal penile erections in these patients. Therefore, 38 patients with noninsulin-dependent diabetes and ED participated in this study. They were assessed with history intake including evaluation by the abridged five-item version of International Index of Erectile Function, clinical and psychiatric assessment and NEVA for three consecutive nights where placebo was given on the second night and tadalafil on the third night. In all, 14 potent males were taken as a control group. Data were analyzed using t-test. Results showed normal patterns in only six (16%) patients (central organic group), while abnormal patterns were observed in the remaining 32 (84%) patients (peripheral organic group). These abnormal patterns showed significant decrease in both the number (P ¼ 0.0001) and duration (P ¼ 0.03) of erectile events compared to those of controls. The percentage of penile blood volume change over baseline also decreased significantly (P ¼ 0.0002) relative to controls. Veno-occlusive dysfunction was the main pathology (23 patients, 72%) as suggested by NEVA. Tadalafil did not significantly change basal nocturnal penile tumescence results in either the central organic or control groups, but it did so significantly in the peripheral organic group (P ¼ 0.02 for duration change and P ¼ 0.01 for % blood volume change). In conclusion, NEVA may suggest some evidence about the pathophysiology of an underlying vasculogenic cause, thus directing towards the next specific step needed for a precise diagnosis. Tadalafil improves nocturnal erections in diabetic patients with peripheral but not central organic impotence.
Introduction
Diabetes mellitus is a well-documented risk factor of erectile dysfunction (ED).
1 ED in diabetes is often multifactorial. Both organic and psychogenic factors are exerting their influence on the ability of the man to gain and maintain erection. Patients may suffer from mild organic erectile dysfunction that will progress to severe ED when a psychogenic factor is contributing to the pathology. 2 Nocturnal penile tumescence (NPT) remains one of the fundamental tools for evaluation and appropriate management of patients with erectile dysfunction. 3 Several tools were used before to evaluate penile tumescence during sleep like stamp test, 4 snap gauge 5 and Rigiscan. 6 Recently, nocturnal electrobioimpedance volumetric assessment (NEVA) of the penis was advented to evaluate nocturnal erectile events and penile blood volume. It is a simple and objective procedure that was used in a reference population without 7 and then with ED. 8 It was also used in assessing response of patients to pharmacologic therapies. 9 However, its role in evaluating the etiologic basis of ED observed in a population of patients with diabetes has not been reported.
The appearance of new oral drugs such as 5-phosphodiesterase inhibitors has led to new approaches in ED management. Tadalafil is one of these drugs. 10 Various authors agree that tadalafil is effective only in response to sexual stimulation, 10, 11 but no reports on its effect on nocturnal penile erections in the absence of any sexual stimulation. Therefore, it would be of interest to evaluate the NEVA patterns in diabetic patients with ED, and demonstrate the extent to which tadalafil may affect the characteristics of nocturnal penile erections in these patients.
Patients and methods

Patients
A group of 38 consecutive patients (age: 46.779 y) with noninsulin-dependent diabetes who presented to Urology Out-Patient Clinic, Masaa Madina Hospital, Madina, Saudi Arabia participated in this study. The mean duration of diabetes in these patients was 12.774.5 y. All patients had ED, as identified by the abridged five-item version of International Index of Erectile Function (IIEF-5) questionnaire, 12 for more than 6 months. As described previously, this questionnaire consists of only five questions including inquiry about intercourse frequency, erection confidence, maintenance frequency, erection firmness and intercourse satisfaction. Each IIEF-5 item is scored on a five-point ordinal scale where lower values represent poorer sexual function. The possible scores for the IIEF-5 range from 1 to 25 (one question has scores of 1-5). A score above 21 is considered as normal erectile function and at or below this cutoff, ED. Patients underwent history intake stressing on the presence of any performance anxiety, relationship conflict or sexual inhibition that may result into psychogenic ED. 13 Clinical examination was also carried out to exclude any penile anatomical disorders as cavernosal fibrosis or Peyronie's disease together with appropriate lab tests and psychological evaluation. A control group consisting of 14 potent males (age 43.279 y) was included in the study. They were also assessed by the IIEF-5 questionnaire. The present evaluation started after obtaining informed consent from all patients and controls, and the purpose of the research has been explained to them. Approval of the Institutional Review Board was also obtained.
NEVA
Three consecutive nights of home NPT monitoring were undertaken in both the patient and control groups. Sexual activity, medications and alcohol were prohibited during sessions of monitoring. On the second night, either the patient or the control received a placebo pill before sleep, while on the third night, 20 mg tadalafil tablet was given. The machine used for NEVA in the current study (Urometrics, St Paul, Minnesota, USA) consisted of three electrode sets and a small recorder. One set of electrodes was placed at the base of penis, another set was placed subcoronally and a reference electrode was placed on the hip. The recorder was worn on the upper thigh. The machine also included a software program and a host-interface connection between the recorder and the computer for downloading and analyzing data at the end of each monitoring period. This job was carried out by a technician not aware of the idea of this research study. Data from the first and second recording nights were compared to verify for any possible first night effect, 6 and used for the diagnostic purposes and basal values. Penile length, cross-sectional area and volume were measured at 1 s intervals for the entire study period. Few events with small changes in the magnitude of penile blood volume suggested arterial insufficiency, while large changes in the blood volume that appeared to be largely a result of changes in penile length and cross-sectional area proposed veno-occlusive dysfunction. 8 On the basis of all performed investigations, patients were classified as having organic (peripheral or central) or situational ED. 14 
Statistics
The raised data were statistically analyzed using SPSS statistical software and t-test for paired samples. Data were expressed as mean7s.d. Differences were considered statistically significant at Pvalue o0.05.
Results
All patients had IIEF-5 scores o21 (Table 1) while all controls had scores 421. Categorization of ED based on three individual diagnostic modalities was nearly similar (Table 2) . NEVA was able to alter the presumptive assignment of ED type in only two (5%) patients. NEVA data of the first and second nights for patients and controls were comparable. NEVA patterns of the patients were normal in six (16%) patients and abnormal in 32 (84%) patients. 
There was no significant (P ¼ 0.46) difference in mean age between both groups (45.178 vs 47.3711 y), while a significant (P ¼ 0.02) difference in the mean duration of DM (7.374.1 y in patients with normal patterns vs 14.375.4 y in patients with abnormal patterns) was found. NEVA patterns in controls (Figure 1) showed that the percentage increase in blood volume over baseline during nocturnal events was significantly higher, and these events were significantly frequent and longer than in patient group with abnormal findings ( Table 3 ). NEVA patterns of these patients suggested arterial insufficiency (Figure 2 ) in nine (28%) patients, veno-occlusive dysfunction (Figure 3 ) in 13 (41%) patients and mixed pathology in 10 (31%) patients. So, the venous pathology was the most common (72%) pathology seen. The mean age of these patients was matched with that of controls with no significant difference ( Table 3) . Psychiatric evaluation was free in nine out of these 32 patients who represented the (pure) peripheral organic impotence subgroup, while it reconfirmed the presence of performance anxiety (10) and relationship conflicts (13) , disclosed during history intake, in the remaining 23 patients who represented the mixed (peripheral organic and situational) impotence subgroup. Both subgroups constituted the group with peripheral organic element in Figure 4 .
In the group of patients with normal NEVA patterns, no significant differences were present between their mean age and basal NEVA parameters and those of controls ( Table 4 ). The psychiatric evaluation revealed depression in four patients and personality disorder in two. These patients represented the central organic impotence group.
Tadalafil did not significantly change basal NPT results in either central organic impotence or control groups. However, there were significant increases in Figure 4) . However, the number of events per night also did not change in these patients.
Discussion
ED has been estimated to have an incidence that varies from a low of 35% to a high of 75% of diabetic patients. 1 The nature of diabetic impotence is NEVA in diabetic ED N Salama multifactorial: etiologies of this impotence are organic, psychogenic or mixed. 2 This present study represents, to the best of our knowledge, the first report of nocturnal changes in penile blood volume in diabetic patients with ED using NEVA maneuver. The results have demonstrated that 84% of our diabetic patients with ED had abnormal patterns suggesting an organic (peripheral) basis for their ED. These results, therefore, agree with those of Veves et al, 15 who found that diabetic ED is mainly organic in 89% of their patients. However, our results looked higher than that reported by other investigators who used NPT and found that about 70% of their diabetic patients had abnormal findings suggesting organic factors which contributed to their impotence. 16 In the present study, there was a high degree of correspondence among patient-reported sex history information, psychiatric evaluation and NEVA measurements of erectile functioning. The NEVA study was able to alter the presumptive assignment of ED type based on patient's reported history in only two patients who were originally thought to have a peripheral organic element, but later the NEVA examination showed both to have a central organic element. The current findings agree with previous investigators who concluded that responses to diagnostic questions during patient's interview were as efficient as standard NPT evaluation in classifying patients into organic and psychogenic categories. 13, 17, 18 NPT evaluation represents one of the objective methods in the assessment of ED. NPT has been forwarded by Karacan et al 19 to distinguish between organic and psychogenic impotence. Various tools of NPT monitoring have been used before depending on the changes in penile circumference. [4] [5] [6] The NEVA system, which was used in the current study, is a relatively new device that employs a new physiologic basis for NPT evaluation. 7, 8 In this device, three electrodes connect to the base and tip of the penis as well as the hip, which represented the ground electrode. The electrodes monitor changes in the relative volume of the penis by measuring the resistance to electric current flow or the impedance, which changes with increasing penile cross-sectional area and length during a nocturnal erection. These impedance changes are converted to data. The device records the number, duration and percentage volume increase of NPT events. Therefore, it can suggest a vasculogenic factor of ED, which was reported to have an incidence as high as 87% in diabetes. 20 NEVAmeasured NPT has been documented to correlate well with that measured by Rigiscan. 7 Besides, the first night effect, which was reported on using many NPT tools, 6 was absent with NEVA, where our first night and second night data were comparable. The absence of this effect with NEVA may be attributed to the nonstressful situation associated with NEVA application to patients who used it at home and not in a sleep lab, and might get adapted to it during instruction at clinic where they applied the electrodes and switched on and off the machine by themselves several times. This easy adaptation to NEVA may be facilitated by its simple light electrodes, which resemble the commonly used ECG electrodes. Besides, NEVA electrodes do not constrain the penis, when applied, like Rigiscan constricting loops, but its electrodes just touch the organ surrounding it incompletely. Lack of this first night effect with NEVA was previously documented by other investigators who used the same machine. 8, 9 Furthermore, no statistical differences between the first and second nights' recordings was found during the evaluation of 32 patients for nocturnal erections on using tools other than NEVA like during polysomnograms as reported by some investigators. 21 
Figure 4
Mean of duration (in minutes) of nocturnal events and the percentage increase in penile blood volume over base line in patients (with central and peripheral organic element of ED) and controls before and after tadalafil intake. 
According to the results of the present study, the mean duration of DM in patients with organic affection was significantly higher. This may go in accordance with Klein et al, 22 who reported that the prevalence of ED increases with the increased duration of DM, but it contradicts with other investigators who believed that ED is an early complication of DM. 23 In the present study, the abnormal NEVA patterns suggested veno-occlusive dysfunction either alone or in combination as the main vascular disorder in about 72% of our diabetic patients. This supports the findings concluded by other investigators who addressed the venous leak as the most common penile vasculogenic pathology seen in diabetic impotent men on duplex Doppler ultrasound. 24, 25 The etiology of vasculogenic impotence among diabetics is also multifactorial. 26 Many studies have implicated the role of microangiopathy and large vessel obliterative atherosclerotic occlusive disease in diabetic impotence associated with arterial insufficiency. 24, 27 Autonomic dysfunction of the penile vascular innervation has been attributed by some, 25 while alterations in penile tunica albuginea and loss of its elasticity has been proposed by others 28 as a cause for veno-occlusive dysfunction. Our study, however, had the shortcoming that it was not performed in association with duplex Doppler ultrasonography. Although a correlation has been reported before between the percentage of penile blood volume increase over baseline volume as evaluated by NEVA and the volume obtained by penile duplex Doppler ultrasound, 8 but this was based on a small number of patients with only two diabetic cases. Therefore, extension of this work to include synchronously penile duplex scanning may give a precise validity to the previous conclusion. In this situation only, NEVA could provide the information offered by duplex scanning, but in a rather noninvasive and relatively inexpensive manner.
Oral therapy, especially in the era of the newly forthcoming 5-phosphodiesterase inhibitors is considered as the first-line management strategies for ED. 29 Tadalafil is a member in this group that enhances the smooth muscle relaxation effect of nitric oxide on the corpus cavernosum by increasing the levels of cyclic 3 0 , 5 0 -guanosine monophosphate (cGMP). 10 To the best of our knowledge, the only report assessing the effect of tadalafil on penile erection using NPT monitoring is the one by PadmaNathan et al. 11 In their work, these authors evaluated the erectile response to tadalafil using Rigiscan during visual sexual stimulation demonstrating improved erectile response under this drug. In the present NEVA study, it was observed that the duration of nocturnal events and the percentage increase of penile blood volume over baseline increased significantly in the group of men with peripheral organic impotence. These data, therefore, support the beneficial effect of tadalafil on nocturnal penile erection in that particular group of diabetic patients even in the absence of any sexual stimulation. The cause of this effect of tadalafil is unclear as the origin of the nervous system signal that induces nocturnal erection is still unknown. 30 However, it may be postulated that the level of cGMP could start to increase during sleep following tadalafil intake and 5-phosphodiesterase inhibition. This elevated level of cGMP could trigger better oxygenation of corpora cavernosa, 31 which could, in turn, improve the nocturnal erections. 32 
Conclusion
NEVA may suggest some evidence about the pathophysiology of an underlying vasculogenic cause, thus directing towards the next specific step needed for a precise diagnosis. Further studies are needed to verify whether these current preliminary findings may constitute the basis for the use of NEVA as a tool capable of and hence recommended for differentiating between different components of ED in diabetic patients. Meanwhile, tadalafil improves nocturnal penile erectile activity in diabetic patients with peripheral organic impotence. This effect could not be demonstrated in diabetic patients with central organic impotence or normal males.
